MarginProbe®- Final Results of the German Post-Market Study in Breast Conserving Surgery of Ductal Carcinoma in Situ
Thill M1, Dittmer C2, Baumann K3, Friedrichs K4, Blohmer JU5. View the study by clicking…
New Research Shows MarginProbe® Reduces Re-Excision Rates for Breast Conserving Surgery by 61%, Giving Renewed Hope to Breast Cancer Patients
A study recently published in the American Journal of Surgery demonstrates that proper use of Dune Medical Devices’ intraoperative margin assessment device, MarginProbe, results in a significant identification of positive margins and a resulting reduction in the re-excision rate for breast conserving surgery - the standard option for patients with early-stage breast cancer.